Zimbabwe health officials acted swiftly after discovering quality problems with certain blood pressure tablets. The Medicines Control Authority recalled all Captopril 25mg tablets from batch number B520K001 manufactured by India's Torrent Pharmaceuticals. These medications treat high blood pressure and heart failure.
Richard Rukwata, who heads the authority, ordered immediate action. He instructed all healthcare facilities and pharmacies to stop distributing or using these medicines right away. Anyone with these tablets should return them to their pharmacy or directly to the regulatory agency. No adverse effects have been reported, but officials launched the recall as a precautionary measure.
The recall demonstrates Zimbabwe's improving ability to identify substandard medications. Rukwata emphasized how the action aligns with their mission to protect public health through quality control of medical products. He pointed out that their regulatory systems have become more effective at catching these issues before they harm patients.
The authority says healthcare workers and patients need to stay alert. They ask everyone to report any suspected quality problems or negative reactions to medications. The authority remains dedicated to maintaining high safety standards for all pharmaceutical products available in Zimbabwe.
Richard Rukwata, who heads the authority, ordered immediate action. He instructed all healthcare facilities and pharmacies to stop distributing or using these medicines right away. Anyone with these tablets should return them to their pharmacy or directly to the regulatory agency. No adverse effects have been reported, but officials launched the recall as a precautionary measure.
The recall demonstrates Zimbabwe's improving ability to identify substandard medications. Rukwata emphasized how the action aligns with their mission to protect public health through quality control of medical products. He pointed out that their regulatory systems have become more effective at catching these issues before they harm patients.
The authority says healthcare workers and patients need to stay alert. They ask everyone to report any suspected quality problems or negative reactions to medications. The authority remains dedicated to maintaining high safety standards for all pharmaceutical products available in Zimbabwe.
